Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Uterine Cervical Neoplasms 3Esophageal Neoplasms 3Lymphatic Metastasis 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Recurrence 1Pathologic Complete Response 1Neoplasm Metastasis 1Melanoma 1Carcinoma, Squamous Cell 1Breast Neoplasms 1

Interventions

Cyclophosphamide 76Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 46Epirubicin 46Letrozole 42pyrotinib 40Fulvestrant 36Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 31exemestane 27Anastrozole 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 19Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × TP protocol × Clear all
NCT04499118 2020-08-05

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

Sichuan Provincial People's Hospital

Phase 2 Unknown
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡